Previous Article | Next Article ![]()
J. Virol., Jan 1995, 141-149, Vol 69, No. 1
R Lower, RR Tonjes, C Korbmacher, R Kurth and J Lower
The human endogenous retrovirus family HTDV/HERV-K codes for the viral
particles observed in teratocarcinoma cell lines. Two types of proviral
genomes exist; these differ in the presence or absence of a stretch of 292
nucleotides. This sequence comprises the amino-terminal part of the env
gene, the putative signal peptide, which overlaps in part with the carboxy
terminus of the pol gene. Type 2 genomes containing this sequence
presumably more closely reflect the structure of the infectious,
replication-competent retrovirus ancestors of the HERV-K family than do
type 1 genomes that lack the sequence. In human teratocarcinoma cell lines,
both variants are expressed. Type 1 genomes, in which pol and env genes are
fused, are deficient in splicing. Type 2 transcripts are spliced to
subgenomic env mRNA and smaller messages. A doubly spliced transcript
encodes a short open reading frame, preliminarily designated cORF (R.
Lower, K. Boller, B. Hasenmeier, C. Korbmacher, N. Mueller-Lantzsch, J.
Lower, and R. Kurth, Proc. Natl. Acad. Sci. USA 90:4480-4484). The genomic
organization of cORF resembles that of nonprimate lentivirus rev genes: the
first exon comprises nearly the entire signal peptide of env, and the
second exon is derived from a different reading frame in the 3' part of the
genome. A nucleolar localization signal, which is also a putative RNA
binding domain, as well as a sequence with similarities to the Rev effector
domain consensus sequence is present in the first exon. Secondary structure
analysis reveals similarities to basic helix-loop-helix proteins. cORF is a
small protein with an apparent molecular mass of 14 kDa which accumulates
in the nucleolus as has been described for Rev proteins.
Copyright © 1995, American Society for Microbiology
Identification of a Rev-related protein by analysis of spliced transcripts of the human endogenous retroviruses HTDV/HERV-K
Paul Ehrlich Institut, Langen, Germany.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|